NANOBIOTIX (EPA:NANO) | WebDisclosure

Basculer en Français

10108	Companies
207120	Keywords
137273	Articles
109785	Press releases

Home
Companies
NANOBIOTIX

PRESS RELEASE

published on 06/12/2024 at 22:15, 1 year 9 months ago

NANOBIOTIX ORGANISE UNE DISCUSSION VIRTUELLE ENTRE EXPERTS SUR LE POTENTIEL DE NBTXR3 EN IMMUNOTHÉRAPIE DANS LE CANCER DE LA TÊTE ET DU COU ET D’AUTRES INDICATIONS LE 18 JUIN 2024
Nanobiotix organise une discussion virtuelle entre experts sur le potentiel de NBTXR3 en immunothérapie dans le cancer de la tête et du cou et d'autres indications le 18 juin 2024

Immunothérapie Cancer De La Tête Et Du Cou NANOBIOTIX NBTXR3 Discussion Virtuelle
PRESS RELEASE

published on 06/12/2024 at 22:15, 1 year 9 months ago

NANOBIOTIX to Host Virtual KOL Event Discussing Potential of NBTXR3 Combined With Immunotherapy in Head and Neck Cancer and Beyond on June 18, 2024
Nanobiotix to host virtual KOL event discussing NBTXR3 combined with immunotherapy in head and neck cancer and beyond on June 18, 2024

Immunotherapy Head And Neck Cancer NANOBIOTIX NBTXR3 Virtual KOL Event
BRIEF

published on 06/11/2024 at 22:20, 1 year 9 months ago

Nanobiotix : Informations Mensuelles sur les Droits de Vote et Actions

Droits De Vote Euronext Actions Nasdaq NANOBIOTIX
BRIEF

published on 06/11/2024 at 22:20, 1 year 9 months ago

Nanobiotix: Monthly Information on Voting Rights and Shares

Voting Rights Euronext Actions Nasdaq NANOBIOTIX
PRESS RELEASE

published on 06/11/2024 at 22:15, 1 year 9 months ago

Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social
Publication mensuelle du nombre total de droits de vote et d'actions de Nanobiotix le 31 mai 2024, conformément à la réglementation financière

Communication Financière Droits De Vote Capital Social Biotechnologie NANOBIOTIX
PRESS RELEASE

published on 06/11/2024 at 22:15, 1 year 9 months ago

Voting Rights and Shares Capital of the Company
Nanobiotix discloses its voting rights and shares capital information as of May 31, 2024, in compliance with regulatory requirements. The company is a clinical biotechnology firm listed on Euronext Paris and Nasdaq

Euronext Paris Voting Rights Nasdaq Shares Capital NANOBIOTIX
BRIEF

published on 06/02/2024 at 16:05, 1 year 9 months ago

Nanobiotix Announces Promising Data on NBTXR3 for Head and Neck Cancer Patients

Clinical Trial Head And Neck Cancer NANOBIOTIX NBTXR3 ASCO
BRIEF

published on 06/02/2024 at 16:05, 1 year 9 months ago

Nanobiotix annonce des données prometteuses sur NBTXR3 pour les patients atteints d'un cancer de la tête et du cou

Essai Clinique Cancer De La Tête Et Du Cou NANOBIOTIX NBTXR3 ASCO
PRESS RELEASE

published on 06/02/2024 at 16:00, 1 year 9 months ago

Nanobiotix Announces New Data Showing Disease Control and Tumor Response in Patients Treated With RT-Activated NBTXR3 Followed By anti-PD-1 For 2l+ R/M HNSCC Naïve or Resistant to Prior anti-PD-1 Therapy
Nanobiotix announces new data from Study 1100 showing disease control and tumor response in patients with R/M HNSCC treated with RT-activated NBTXR3 followed by anti-PD-1. Investor event scheduled on June 2nd

NANOBIOTIX Study 1100 R/M HNSCC RT-activated NBTXR3 Anti-PD-1
BRIEF

published on 05/28/2024 at 22:20, 1 year 9 months ago

NANOBIOTIX Présente de Nouvelles Données à l'ASCO 2024

Immunothérapie NANOBIOTIX NBTXR3 ASCO Phase 1

Accesswire

Published on 03/27/2026 at 22:45, 57 minutes ago

Caledonia Mining Corporation Plc - Notification of Relevant Change to Significant Shareholder
Published on 03/27/2026 at 22:30, 1 hour 12 minutes ago

Usha Resources Completes Extended Induced Polarization Survey at the Southern Arm Property
Published on 03/27/2026 at 22:30, 1 hour 12 minutes ago

Troubadour Announces Share Consolidation
Published on 03/27/2026 at 22:00, 1 hour 42 minutes ago

AI/ML Innovations Inc. Announces Closing of First Tranche of Private Placement to Raise $950,000
Published on 03/27/2026 at 22:00, 1 hour 42 minutes ago

Jericho Energy Appoints Jake Royster as COO to Advance AI-Driven Energy Platform and Enhance Operations

View all ACCESSWIRE

EQS Group

Published on 03/27/2026 at 21:58, 1 hour 44 minutes ago

Kaufman & Broad SA: Availability of the Universal Registration Document 2025
Published on 03/27/2026 at 21:58, 1 hour 44 minutes ago

Kaufman & Broad SA: Mise à disposition du Document d'Enregistrement Universel 2025
Published on 03/27/2026 at 20:08, 3 hours 34 minutes ago

EQS-Adhoc: CECONOMY AG: Information on the ongoing public takeover process – uncertainty regarding FDI clearance in Austria
Published on 03/27/2026 at 19:30, 4 hours 12 minutes ago

Turning Potential into Reality: Future 500 Ignites Scale-Up Momentum in Europe
Published on 03/27/2026 at 19:30, 4 hours 12 minutes ago

FONDAZIONE MAIRE PRESENTED IN BERLIN THE "CLIMATE GOALS" STUDY IN THE FRAMEWORK OF MAIRE EUROPEAN STRATEGY LEVERAGING ON GERMANY

Les Echos

Published on 03/27/2026 at 19:06, 4 hours 36 minutes ago

Mersen : Déclaration des transactions sur actions propres
Published on 03/27/2026 at 19:06, 4 hours 36 minutes ago

Mersen: Disclosure of trading own shares
Published on 03/27/2026 at 18:52, 4 hours 50 minutes ago

Crédit Agricole CIB announces the publication of its 2025 Universal Registration Document
Published on 03/27/2026 at 18:52, 4 hours 50 minutes ago

Crédit Agricole CIB annonce la publication de son Document d’enregistrement universel 2025
Published on 03/27/2026 at 18:40, 5 hours 2 minutes ago

2026 share capital increase reserved for members of the Saint-Gobain Group employee savings plan

View all LES ECHOS COMFI WIRE